Podcast 22: Interview with Aaron Kesselheim about his meta-analysis of the efficacy of proprietary versus generic cardiovascular drugs.

This week, in addition to the usual news roundup, we talk with Dr. Aaron Kesselheim about his JAMA paper on the equivalence between proprietary and generic cardiovascular drugs. The data and the editorials are often at odds on this question. Have a listen, and if you want to react to any of this, call 1-617-440-4374. Links for this issue: –Vitamin D American Academy of Dermatology guidelines Physician’s First Watch coverage –Controlling hypertension NEJM abstract Journal Watch Cardiology coverage Physician’s First Watch coverage — Work hours for residents Institute of Medicine recommendations Physician’s First Watch coverage –Depression in stable coronary disease Pubmed abstract Journal Watch Cardiology coverage –Generic versus proprietary cardiovascular drugs JAMA abstract Physician’s First Watch coverage The post Podcast 22: Interview with Aaron Kesselheim about his meta-analysis of the efficacy of proprietary versus generic cardiovascular drugs. first appeared on Clinical Conversations.